Clinical trialNCT02464163CompletedPhase 1/PHASE2Interventional

Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older

SponsorProtein Sciences CorporationEnrollment407Influenza

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to investigate the safety and immunogenicity of a recombinant hemagglutinin (rHA) influenza vaccine derived from A/Anhui/1/2013 (H7N9) administered at 3 dose levels in adjuvanted (SE) rHA formulations and 1 dose levels in an unadjuvanted rHA formulation.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

John J Treanor, MD
University of Rochester Center for Vaccine Studies
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Coastal Clinical Research
Mobile, Alabama, United States
Avail Clinical Research
DeLand, Florida, United States
Meridian Clinical Research
Savannah, Georgia, United States
Meridian Clinical Research
Omaha, Nebraska, United States
Regional Clinical Research, Inc.
Endwell, New York, United States
Rapid Medical Research, Inc.
Cleveland, Ohio, United States
Benchmark Reseach
Austin, Texas, United States
Benchmark Research - Fort Worth
Fort Worth, Texas, United States
Jean Brown Research
Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PanblokRHA adjuvant

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jul 2015
Primary completion: 31 Aug 2016
Completion: 31 Aug 2016
Last update posted: 26 Oct 2017
Registered enrollment: 407
Registry id: NCT02464163

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.